Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly grow ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the momentum, experts worry.

in Boston for the BIO International Convention—the world’s largest gathering of biotech leaders and innovators. Together, we’ll share knowledge, spark collaborations, and work toward building a ...

CRISPR Therapeutics' stock decline is likely influenced by Editas Medicine's struggles, but CRISPR remains a distinct and stronger company with a promising long-term outlook. CRISPR's strategic ...

Shares of CRISPR Therapeutics CRSP have lost more than 30% in the past year. Though the stock soared at the onset of 2024, thanks to the FDA approval of its one-shot gene therapy Casgevy for two ...

The Boston Zoning Commission voted to approve a new zoning standard requiring new buildings to meet net zero carbon emissions ...

Our administration is proud to help the building evolve into a space that is accessible to the community while maintaining its historic character," Wu said in a statement. "Boston City Hall is ...

Quantum computing, long relegated to the realm of the theoretical, feels like it is back on the agenda as a potentially ...

The leader of Breaktime, a homelessness nonprofit, engineered a $6 million deal to purchase a five-story building.